SPMDvsWDNA
SPDR Portfolio S&P 400 Mid Cap ETF against WisdomTree BioRevolution Fund — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPMD | WDNA | |
|---|---|---|
| Expense ratio | 0.030% | 0.45% |
| Assets | $17.9B | $2534.72T |
| Net flow, 1 month | +$207M | — |
| Net flow, 1 year | +$2.1B | — |
| Return, YTD | +11.0% | +40.3% |
| Return, 1 year | +11.9% | +41.7% |
| Avg daily volume | 1.6M | 4K |
| Holdings | 401 | 91 |
| Listed | Nov 8, 2005 | Jun 3, 2021 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS